Reid Merryman, Md
Clinical trials sponsored by Reid Merryman, Md, explained in plain language.
-
New drug duo aims to control lymphoma without lifelong drugs
Disease control Recruiting nowThis study tests whether combining two drugs, epcoritamab and rituximab, can effectively treat follicular lymphoma in people who haven't had treatment before. About 100 adults with this slow-growing blood cancer will receive the drug combination. The goal is to see if the cancer …
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New drug cocktail aims to beat back lymphoma in relapsed patients
Disease control Recruiting nowThis study tests a combination of three drugs—epcoritamab, zanubrutinib, and rituximab—in people with follicular lymphoma or marginal zone lymphoma that has come back or not responded to prior treatment. The goal is to see how well the combo works at shrinking tumors and to check…
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated May 13, 2026 16:01 UTC